“Fighting fraud is a great idea,” editorializes the Charleston Daily Mail. But a proposed state bill modeled after the federal False Claims Act won’t improve the accountability of the government. Rather, it will encourage frivolous litigation and enrich plaintiffs’ lawyers, the Daily Mail writes.
A group of 28 Republican legislators sent a letter to the FDA asking the agency to reconsider a proposal that would allow generic drugmakers to change a label without the agency’s approval. In September, ILR president Lisa Rickard wrote the rule change is “a prescription for mega lawsuits.” CQ
Shareholder lawsuits against Johnson & Johnson have been dismissed after the lawyer fees were resolved, reports Main Justice. Some investors objected to the $10 million fee request for the suits stemming from the company’s FCPA settlements, questioning whether the lawyers deserved the payout.